Abbott’s Q4 2023 Earnings and Bullish 2024 Outlook: A Strong Performanceby Mark Eisenberg 25.01.2024Abbott Laboratories reports strong Q4 earnings and projects a promising outlook for 2024 with growth in various business segments. #AbbottLabs ...
“Apple’s Earnings: Morgan Stanley Eyes Clearing Event”by Terry Bingman 24.01.2024Investors await Apple's earnings release, which Morgan Stanley believes will offer clarity and refocus on the 'Edge AI' opportunity and ...
Texas Instruments Revenue Falls Short of Q4 Expectationsby Mark Eisenberg 24.01.2024Texas Instruments reports decline in Q4 revenue but remains optimistic about free cash flow. Stock price takes a hit, highlighting ...
Procter & Gamble Raises Full-Year EPS Forecast, Shares Soarby Terry Bingman 23.01.2024Procter & Gamble's Q2 financial results exceed EPS estimates but fall slightly short on revenue, prompting an increase in stock ...
R1T Demand Spurs Needham’s Bullish Outlook on Rivianby Mark Eisenberg 09.01.2024Investment firm Needham reiterates its bullish outlook on Rivian as R1T demand surges, setting a price target of $25.00 for ...
Lululemon Stock Resilient Amid Market Challengesby Mark Eisenberg 18.08.2023Lululemon Athletica has shown resilience and formed a bullish pattern, outperforming its industry with a 17% YTD gain. With strong ...